Linaclotide developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation, and is a potent and selective guanylate cyclase C agonist.
Molecular Weight:
1526.74
CAS Number:
[851199-59-2]
Formula:
C59H79N15O21S6
Target:
Guanylate cyclase
* VAT and and shipping costs not included. Errors and price changes excepted